Home Cart Sign in  
Chemical Structure| 333745-53-2 Chemical Structure| 333745-53-2

Structure of LX2343
CAS No.: 333745-53-2

Chemical Structure| 333745-53-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

LX2343 is a BACE1 enzyme inhibitor with an IC50 value of 11.43±0.36 μM. LX2343 acts as a non-ATP competitive PI3K inhibitor with an IC50 of 15.99±3.23 μM. LX2343 stimulates autophagy in its promotion of Aβ clearance.

Synonyms: LX2343

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of LX2343

CAS No. :333745-53-2
Formula : C22H19ClN2O6S
M.W : 474.91
SMILES Code : O=C(NC1=CC=C(OCO2)C2=C1)CN(C3=CC(Cl)=CC=C3OC)S(=O)(C4=CC=CC=C4)=O
Synonyms :
LX2343
MDL No. :MFCD02578482
InChI Key :ZGYSGIYKAVUVOR-UHFFFAOYSA-N
Pubchem ID :1000980

Safety of LX2343

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Mouse primary cortical neurons 5–20 μmol/L 24 hours LX2343 significantly attenuated STZ-induced apoptosis in primary cortical neurons by alleviating oxidative stress and inhibiting the JNK/p38 and pro-apoptotic pathways. Acta Pharmacol Sin. 2017 Aug;38(8):1104-1119
SH-SY5Y cells 5–20 μmol/L 24 hours LX2343 significantly attenuated STZ-induced apoptosis in SH-SY5Y cells by alleviating oxidative stress and inhibiting the JNK/p38 and pro-apoptotic pathways. Acta Pharmacol Sin. 2017 Aug;38(8):1104-1119
SH-SY5Y cells 20μmol/L LX2343 as a PI3K inhibitor stimulated autophagy in the promotion of Aβ clearance Acta Pharmacol Sin. 2024 Sep;45(9):1992-1994

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Sprague Dawley rats ICV-STZ-induced AD model rats Intraperitoneal injection 7 and 21 mg/kg/d Once daily for 5 weeks LX2343 efficiently improved cognitive deficits in ICV-STZ rats by suppressing oxidative stress-induced neuronal apoptosis and tauopathy. Acta Pharmacol Sin. 2017 Aug;38(8):1104-1119

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.11mL

0.42mL

0.21mL

10.53mL

2.11mL

1.05mL

21.06mL

4.21mL

2.11mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories